Literature DB >> 15453267

Parkin transcript variants in rat and human brain.

Velia Dagata1, Sebastiano Cavallaro.   

Abstract

Alternative splicing has an important role in expanding protein diversity. We have identified complementary DNA species from adult rat and fetal human brain encoding seven new splice variants of parkin, a gene mutated in autosomal recessive juvenile parkinsonism (ARJP). Alternative splicing affects almost all previously characterized exons, plus 3 new exons of 72, 156, and 180 nucleotides. This creates the potential to express hundreds of different isoforms. The encoded parkin isoforms have different amino acid composition, post-translational modifications, and, most important, molecular architectures. They diverge for the presence or absence of the ubiquitin-like domain, one or two C3HC4 ring fingers, the in-between ring fingers (IBR) domain, and a thiol proteases active site, which has not been previously characterized. Distinct expression patterns occur in primary cultures of neuronal and glial cells. Extensive splicing of parkin produces regional and structural diversity and may have important implications for the pathogenetic mechanisms underlying ARJP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15453267     DOI: 10.1023/b:nere.0000035807.25370.5e

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Parkin expression in the adult mouse brain.

Authors:  C C Stichel; M Augustin; K Kühn; X R Zhu; P Engels; C Ullmer; H Lübbert
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

2.  The genomic structure and promoter region of the human parkin gene.

Authors:  S Asakawa; A Takayanagi; T Sasaki; A Shimizu; A Shintani; K Kawasaki; A J Mungall; S Beck; S Minoshima; N Shimizu
Journal:  Biochem Biophys Res Commun       Date:  2001-09-07       Impact factor: 3.575

3.  Regional and cellular expression of the parkin gene in the rat cerebral cortex.

Authors:  V D'Agata; M Grimaldi; A Pascale; S Cavallaro
Journal:  Eur J Neurosci       Date:  2000-10       Impact factor: 3.386

4.  Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene.

Authors:  N Hattori; H Matsumine; S Asakawa; T Kitada; H Yoshino; B Elibol; A J Brookes; Y Yamamura; T Kobayashi; M Wang; A Yoritaka; S Minoshima; N Shimizu; Y Mizuno
Journal:  Biochem Biophys Res Commun       Date:  1998-08-28       Impact factor: 3.575

5.  Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group.

Authors:  C B Lücking; N Abbas; A Dürr; V Bonifati; A M Bonnet; T de Broucker; G De Michele; N W Wood; Y Agid; A Brice
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

6.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

7.  Differential expression of the parkin gene in the human brain and peripheral leukocytes.

Authors:  Y Sunada; F Saito; K Matsumura; T Shimizu
Journal:  Neurosci Lett       Date:  1998-10-02       Impact factor: 3.046

8.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

9.  Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.

Authors:  S Cavallaro; A Copani; V D'Agata; S Musco; S Petralia; C Ventra; F Stivala; S Travali; P L Canonico
Journal:  Mol Pharmacol       Date:  1996-07       Impact factor: 4.436

Review 10.  Parkin's substrates and the pathways leading to neuronal damage.

Authors:  Mark R Cookson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

View more
  19 in total

1.  PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

Authors:  Katarzyna Gaweda-Walerych; Krzysztof Safranow; Barbara Jasinska-Myga; Monika Bialecka; Gabriela Klodowska-Duda; Monika Rudzinska; Krzysztof Czyzewski; Stephanie A Cobb; Jaroslaw Slawek; Maria Styczynska; Grzegorz Opala; Marek Drozdzik; Kenya Nishioka; Matthew J Farrer; Owen A Ross; Zbigniew K Wszolek; Maria Barcikowska; Cezary Zekanowski
Journal:  Parkinsonism Relat Disord       Date:  2012-02-22       Impact factor: 4.891

2.  Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease.

Authors:  E K Tan; H Shen; J M M Tan; K L Lim; S Fook-Chong; W P Hu; M C Paterson; V R Chandran; K Yew; C Tan; Y Yuen; R Pavanni; M C Wong; K Puvan; Y Zhao
Journal:  Neurogenetics       Date:  2005-08-06       Impact factor: 2.660

3.  Proteomic Analysis of Parkin Isoforms Expression in Different Rat Brain Areas.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Rita Reitano; Sebastiano Cavallaro; Velia D'Agata
Journal:  Protein J       Date:  2016-10       Impact factor: 2.371

Review 4.  WT1 Alternative Splicing: Role of Its Isoforms in Neuroblastoma.

Authors:  Daniela Maria Rasà; Agata Grazia D'Amico; Grazia Maugeri; Sebastiano Cavallaro; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2017-05-22       Impact factor: 3.444

5.  Parkin-deficient mice are not a robust model of parkinsonism.

Authors:  Francisco A Perez; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

6.  Mitochondrial and calcium perturbations in rat CNS neurons induce calpain-cleavage of Parkin: Phosphatase inhibition stabilizes pSer65Parkin reducing its calpain-cleavage.

Authors:  Hu Wang; Fanny Cheung; Anna C Stoll; Patricia Rockwell; Maria E Figueiredo-Pereira
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-02-21       Impact factor: 5.187

7.  Expression pattern of parkin isoforms in lung adenocarcinomas.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Gaetano Magro; Lucia Salvatorelli; Filippo Drago; Velia D'Agata
Journal:  Tumour Biol       Date:  2015-02-06

8.  SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease.

Authors:  Lina A Shehadeh; Kristine Yu; Liyong Wang; Alexandra Guevara; Carlos Singer; Jeffery Vance; Spyridon Papapetropoulos
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

9.  Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.

Authors:  Katrin Beyer; Montserrat Domingo-Sàbat; Jordi Humbert; Cristina Carrato; Isidro Ferrer; Aurelio Ariza
Journal:  Neurogenetics       Date:  2008-03-12       Impact factor: 2.660

10.  Role of E3 ubiquitin ligases in lung cancer.

Authors:  Barbara C Snoek; Leonie Ham de Wilt; Gerrit Jansen; Godefridus J Peters
Journal:  World J Clin Oncol       Date:  2013-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.